Metrics as of 10/14/2026, 11:47 PM (Berlin time), refresh in progress.
Alps Group Stock
Alps Group Inc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Malaysia
- CEO
- Seng Kong Tham
- Employees
- 93
- Market cap
- $58 M
- IPO
- 31/10/2025
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a…
Alps Group stock: price history
1D
-0.0%
1W
+1.6%
1M
-12.5%
6M
-65.0%
YTD
-59.8%
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~330% stronger price swings than usual
Ask the agents about Alps Group
Alps Group stock metrics
P/E
-0.73
P/B
-0.42
EV/EBITDA
-65.65
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
-0.19
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
166,399,253
AVG. DAILY VOLUME (30D)
54,273
Institutional holders
Comparable stocks
Frequently asked questions about Alps Group stock
What does Alps Group do?
Alps Group Inc is a company in the Healthcare sector, Biotechnology industry, headquartered in Malaysia.
The CEO is Seng Kong Tham, the company employs around 93 people.
The IPO was on 31/10/2025; the stock trades on NASDAQ under the ticker ALPS.
When does Alps Group report next?
Around past earnings, price swings were roughly 330% stronger than usual.
Does Alps Group pay a dividend?
No, Alps Group currently does not pay a dividend.
Which stocks are comparable to Alps Group?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Alps Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alps Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.